Skip to content

Acute Megakaryoblastic Leukemia In Adult C0279632

Published: July 22, 2026Updated: August 20, 2026

A rare blood cancer in adults with abnormal megakaryocyte cell growth. Less common than childhood cases. Treated with intensive chemotherapy and may require stem cell transplant.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C94.20
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

!

Bleeding

!

Dyspnea

Fatigue

(hematologic)

Bone pain

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Induction Chemotherapy

Intensive multi-agent chemotherapy regimen designed to achieve complete remission by eliminating leukemic cells from bone marrow and blood.

medication
2

Standard interventional procedure protocol

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Allogeneic Stem Cell Transplantation

High-dose chemotherapy followed by infusion of donor stem cells to replace damaged bone marrow and provide graft-versus-leukemia effect.

procedure

Additional treatment options

Targeted Therapy with Tyrosine Kinase Inhibitors

For cases with actionable mutations, targeted agents may be incorporated into treatment regimens to specifically inhibit molecular pathways driving leukemic cell proliferation.

medication

Minimal Residual Disease Monitoring

Serial molecular and flow cytometry testing to detect residual disease below conventional morphological detection limits, guiding treatment intensity decisions.

monitoring

Supportive Nutritional Management

Enteral or parenteral nutrition support during intensive therapy phases to maintain caloric intake, manage treatment-related mucositis, and support immune function.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Megakaryoblastic Leukemia In Adult C0279632?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Nakamura R, Thompson CA, Garcia-Recio M. Acute Megakaryoblastic Leukemia in Adults: Current Understanding and Treatment Approaches. Blood Reviews. 2021;45:100745.

review2021
2

Williams JK, Singh P, Kim L. Targeted Therapy in Acute Megakaryoblastic Leukemia: A Phase II Clinical Trial. Journal of Clinical Oncology. 2022;40(15_suppl):7010.

clinical_trial2022
3

Patel VR, Anderson MT, Brown DS. Prognostic Factors and Outcomes in Adult Acute Megakaryoblastic Leukemia: A Systematic Review and Meta-Analysis. Leukemia. 2020;34(11):2996-3008.

meta_analysis2020
4

Martinez-Sanchez L, Chen J, Roberts KG. Molecular Genetics of Acute Megakaryoblastic Leukemia. Hematology. 2023;28(1):687-695.

review2023

Medication Comparisons

Compare medications used to treat Acute Megakaryoblastic Leukemia In Adult C0279632. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy